# Clustering Approach 2 : METHLYATION_CNMF
Index	Clinical feature name	Test type	P value	Comment
1	Time to Death	logrank test	0.0260384890160887	Range of duration = 0.03 to 158.83, nDeath = 5, nCensor = 222
2	AGE	ANOVA	0.0642104186772407	Range of values = 18 to 89, Mean = 46.7904, StdDev = 14.9288
3	GENDER	Fisher's exact test	0.054399864444178	nTypes = 2 (FEMALE/MALE), nPatients = 169/60
4	HISTOLOGICAL.TYPE	Chi-square test	0.00514690419042142	nTypes = 4 (OTHER  SPECIFY/THYROID PAPILLARY CARCINOMA - CLASSICAL/USUAL/THYROID PAPILLARY CARCINOMA - FOLLICULAR (>= 99% FOLLICULAR PATTERNED)/THYROID PAPILLARY CARCINOMA - TALL CELL (>= 50% TALL CELL FEATURES)), nPatients = 3/184/16/26
5	RADIATIONS.RADIATION.REGIMENINDICATION	Fisher's exact test	0.42729302662146	nTypes = 2 (NO/YES), nPatients = 11/218
6	RADIATIONEXPOSURE	Fisher's exact test	0.643658086301726	nTypes = 2 (NO/YES), nPatients = 197/8, nMissing = 24
7	DISTANT.METASTASIS	Chi-square test	0.553005506473733	nTypes = 3 (M0/M1/MX), nPatients = 132/4/93
8	EXTRATHYROIDAL.EXTENSION	Chi-square test	0.00109602072221043	nTypes = 3 (MINIMAL (T3)/MODERATE/ADVANCED (T4A)/NONE), nPatients = 76/9/139, nMissing = 5
9	LYMPH.NODE.METASTASIS	Chi-square test	0.0145110655622603	nTypes = 5 (N0/N1/N1A/N1B/NX), nPatients = 92/27/56/33/21
10	COMPLETENESS.OF.RESECTION	Chi-square test	0.0796639324176657	nTypes = 4 (R0/R1/R2/RX), nPatients = 182/22/1/13, nMissing = 11
11	NUMBER.OF.LYMPH.NODES	ANOVA	0.0391332986791344	Range of values = 0 to 40, Mean = 3.54255, StdDev = 5.62208, nMissing = 41
12	TUMOR.STAGECODE	ANOVA	NA	Range of values = Inf to -Inf, Mean = NaN, StdDev = NA, nMissing = 229
13	NEOPLASM.DISEASESTAGE	Chi-square test	0.0317230261432593	nTypes = 5 (STAGE I/STAGE II/STAGE III/STAGE IVA/STAGE IVC), nPatients = 132/16/55/22/3, nMissing = 1
14	MULTIFOCALITY	Fisher's exact test	0.612177658583884	nTypes = 2 (MULTIFOCAL/UNIFOCAL), nPatients = 105/121, nMissing = 3
15	TUMOR.SIZE	ANOVA	0.0876110639887255	Range of values = 0.3 to 8.2, Mean = 2.82634, StdDev = 1.6026, nMissing = 43